Biodegradable Janus nanoparticles for local pulmonary delivery of hydrophilic and hydrophobic molecules to the lungs

Langmuir

Volumn 30, Issue 43, 2014, Pages 12941-12949

  Garbuzenko, Olga B ^a   Winkler, Jennifer ^b   Tomassone, M Silvina ^b   Minko, Tamara ^a  

^a RUTGERS UNIVERSITY   (United States)

^b The State University of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROPHILIC AND HYDROPHOBIC; JANUS NANOPARTICLES; PULMONARY DELIVERY;

ANTINEOPLASTIC AGENT; CURCUMIN; DOXORUBICIN; DRUG CARRIER; NANOPARTICLE;

ANIMAL; ANISOTROPY; CHEMICAL PHENOMENA; CHEMISTRY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG; METABOLISM; MOUSE; MUTAGEN TESTING; PARTICLE SIZE; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ADMINISTRATION, INHALATION; ANIMALS; ANISOTROPY; ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CURCUMIN; DOXORUBICIN; DRUG CARRIERS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LUNG; MICE; MUTAGENICITY TESTS; NANOPARTICLES; PARTICLE SIZE;

EID: 84908529980     PISSN: 07437463     EISSN: 15205827     Source Type: Journal    
DOI: 10.1021/la502144z     Document Type: Article

References (46)

1. Haley, B.; Frenkel, E. Nanoparticles for drug delivery in cancer treatment Urol. Oncol. 2008, 26, 57-64
2. Matsumura, Y. The drug discovery by nanomedicine and its clinical experience Jpn. J. Clin. Oncol. 2014, 44, 515-525
3. Moghimi, S. M. Cancer nanomedicine and the complement system activation paradigm: Anaphylaxis and tumour growth J. Controlled Release 2014, 190, 556-562
4. Saadeh, Y.; Leung, T.; Vyas, A.; Chaturvedi, L. S.; Perumal, O.; Vyas, D. Applications of nanomedicine in breast cancer detection, imaging, and therapy J. Nanosci. Nanotechnol. 2014, 14, 913-923
5. Drbohlavova, J.; Chomoucka, J.; Adam, V.; Ryvolova, M.; Eckschlager, T.; Hubalek, J.; Kizek, R. Nanocarriers for anticancer drugs - New trends in nanomedicine Curr. Drug Metab. 2013, 14, 547-564
6. Rizzo, L. Y.; Theek, B.; Storm, G.; Kiessling, F.; Lammers, T. Recent progress in nanomedicine: Therapeutic, diagnostic and theranostic applications Curr. Opin Biotechnol. 2013, 24, 1159-1166
7. Etheridge, M. L.; Campbell, S. A.; Erdman, A. G.; Haynes, C. L.; Wolf, S. M.; McCullough, J. The big picture on nanomedicine: the state of investigational and approved nanomedicine products Nanomed.: Nanotechnol., Biol., Med. 2013, 9, 1-14
8. Mitra, A.; Nan, A.; Line, B. R.; Ghandehari, H. Nanocarriers for nuclear imaging and radiotherapy of cancer Curr. Pharm. Des 2006, 12, 4729-4749
9. Shah, V.; Taratula, O.; Garbuzenko, O. B.; Patil, M. L.; Savla, R.; Zhang, M.; Minko, T. Genotoxicity of different nanocarriers: Possible modifications for the delivery of nucleic acids Curr. Drug Discov. Technol. 2013, 10, 8-15
10. Garbuzenko, O. B.; Saad, M.; Pozharov, V. P.; Reuhl, K. R.; Mainelis, G.; Minko, T. Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 10737-10742
11. Taratula, O.; Kuzmov, A.; Shah, M.; Garbuzenko, O. B.; Minko, T. Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA J. Controlled Release 2013, 171, 349-357
12. Mussi, S. V.; Sawant, R.; Perche, F.; Oliveira, M. C.; Azevedo, R. B.; Ferreira, L. A.; Torchilin, V. P. Novel nanostructured lipid carrier co-loaded with doxorubicin and docosahexaenoic acid demonstrates enhanced in vitro activity and overcomes drug resistance in MCF-7/Adr cells Pharm. Res. 2014, 8, 1882-1892
13. Wang, T.; Hartner, W. C.; Gillespie, J. W.; Praveen, K. P.; Yang, S.; Mei, L. A.; Petrenko, V. A.; Torchilin, V. P. Enhanced tumor delivery and antitumor activity in vivo of liposomal doxorubicin modified with MCF-7-specific phage fusion protein Nanomed.: Nanotechnol., Biol., Med. 2014, 10, 421-430
14. Tong, S. W.; Xiang, B.; Dong, D. W.; Qi, X. R. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles Int. J. Pharm. 2012, 434, 413-419
15. Zhao, B. J.; Ke, X. Y.; Huang, Y.; Chen, X. M.; Zhao, X.; Zhao, B. X.; Lu, W. L.; Lou, J. N.; Zhang, X.; Zhang, Q. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats J. Drug Target 2011, 19, 382-390
16. Abouzeid, A. H.; Patel, N. R.; Rachman, I. M.; Senn, S.; Torchilin, V. P. Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin J. Drug Target 2013, 21, 994-1000
17. Sawant, R. R.; Jhaveri, A. M.; Koshkaryev, A.; Qureshi, F.; Torchilin, V. P. The effect of dual ligand-targeted micelles on the delivery and efficacy of poorly soluble drug for cancer therapy J. Drug Target 2013, 21, 630-638
18. Shcharbin, D.; Shakhbazau, A.; Bryszewska, M. Poly(amidoamine) dendrimer complexes as a platform for gene delivery Exp. Opin. Drug Deliv. 2013, 10, 1687-1698
19. Mignani, S.; El Kazzouli, S.; Bousmina, M.; Majoral, J. P. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview Adv. Drug Deliv Rev. 2013, 65, 1316-1330
20. Najlah, M.; DEmanuele, A. Synthesis of dendrimers and drug-dendrimer conjugates for drug delivery Curr. Opin Drug Discov. Devel. 2007, 10, 756-767
21. Neerman, M. F.; Zhang, W.; Parrish, A. R.; Simanek, E. E. In vitro and in vivo evaluation of a melamine dendrimer as a vehicle for drug delivery Int. J. Pharm. 2004, 281, 129-132
22. He, Q.; Shi, J. MSN anti-cancer nanomedicines: Chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition Adv. Mater. 2014, 26, 391-411
23. Taratula, O.; Garbuzenko, O. B.; Chen, A. M.; Minko, T. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA J. Drug Target 2011, 19, 900-914
24. Perro, A.; Reculusa, S.; Ravaine, S.; Bourgeat-Lami, E.; Duguet, E. Design and synthesis of Janus micro- and nanoparticles J. Mater. Chem. 2005, 15, 3745-3760
25. Romanski, F. S.; Winkler, J. S.; Riccobene, R. C.; Tomassone, M. S. Production and characterization of anisotropic particles from biodegradable materials Langmuir 2012, 28, 3756-3765
26. Yoo, J. W.; Doshi, N.; Mitragotri, S. Adaptive micro and nanoparticles: Temporal control over carrier properties to facilitate drug delivery Adv. Drug Deliv Rev. 2011, 63, 1247-1256
27. Champion, J. A.; Mitragotri, S. Role of target geometry in phagocytosis Proc. Natl. Acad. Sci. U. S. A. 2006, 103, 4930-4934
28. Tomasini, M. D.; Zablocki, K.; Petersen, L. K.; Moghe, P. V.; Tomassone, M. S. Coarse grained molecular dynamics of engineered macromolecules for the inhibition of oxidized low-density lipoprotein uptake by macrophage scavenger receptors Biomacromolecules 2013, 14, 2499-2509
29. Mainardes, R. M.; Evangelista, R. C. PLGA nanoparticles containing praziquantel: Effect of formulation variables on size distribution Int. J. Pharm. 2005, 290, 137-144
30. Niwa, T.; Takeuchi, H.; Hino, T.; Kunou, N.; Kawashima, Y. In vitro drug release behavior of D,L-lactide/glycolide copolymer (PLGA) nanospheres with nafarelin acetate prepared by a novel spontaneous emulsification solvent diffusion method J. Pharm. Sci. 1994, 83, 727-732
31. Ubrich, N.; Bouillot, P.; Pellerin, C.; Hoffman, M.; Maincent, P. Preparation and characterization of propranolol hydrochloride nanoparticles: A comparative study J. Controlled Release 2004, 97, 291-300
32. Convention, U. S. P. USP 30; United States Pharmacopeial Convention, 2006.
33. Basu, S.; Harfouche, R.; Soni, S.; Chimote, G.; Mashelkar, R. A.; Sengupta, S. Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy Proc. Natl. Acad. Sci. U. S. A. 2009, 106, 7957-7961
34. Mainelis, G.; Seshadri, S.; Garbuzenko, O. B.; Han, T.; Wang, Z.; Minko, T. Characterization and application of a nose-only exposure chamber for inhalation delivery of liposomal drugs and nucleic acids to mice J. Aerosol Med. Pulm. Drug Deliv. 2013, 26, 345-354
35. Kumari, A.; Yadav, S. K.; Yadav, S. C. Biodegradable polymeric nanoparticles based drug delivery systems Colloids Surf., B 2010, 75, 1-18
36. Makadia, H. K.; Siegel, S. J. Poly Lactic- co -glycolic acid (PLGA) as biodegradable controlled drug delivery carrier Polymers 2011, 3, 1377-1397
37. Sonaje, K.; Italia, J. L.; Sharma, G.; Bhardwaj, V.; Tikoo, K.; Kumar, M. N. V. R. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats Pharm. Res. 2007, 24, 899-908
38. Gao, Z. H.; Crowley, W. R.; Shukla, A. J.; Johnson, J. R.; Reger, J. F. Controlled release of contraceptive steroids from biodegradable and injectable gel formulations: in vivo evaluation Pharm. Res. 1995, 12, 864-868
39. Sahoo, S. K.; Panyam, J.; Prabha, S.; Labhasetwar, V. Residual polyvinyl alcohol associated with poly (d, l -lactide- co -glycolide) nanoparticles affects their physical properties and cellular uptake J. Controlled Release 2002, 82, 105-114
40. Chong, S. F.; Smith, A. A.; Zelikin, A. N. Microstructured, functional PVA hydrogels through bioconjugation with oligopeptides under physiological conditions Small 2013, 9, 942-950
41. Matsumura, S.; Toshima, K. biodegradation of poly(vinyl alcohol) and vinyl alcohol block as biodegradable segment. In Hydrogels and Biodegradable Polymers for Bioapplications; American Chemical Society: Washington, D.C., 1996; Vol. 627, pp 137-148.
42. Manousaki, E.; Psillakis, E.; Kalogerakis, N.; Mantzavinos, D. Degradation of sodium dodecylbenzene sulfonate in water by ultrasonic irradiation Water Res. 2004, 38, 3751-3759
43. Minko, T. Drug delivery systems. In Martins Physical Pharmacy and Pharmaceutical Sciences, 5 ed.; Sinko, P., Ed.; Lippincott Williams and Wilkins: New York, 2006; pp 629-680.
44. Garbuzenko, O. B.; Mainelis, G.; Taratula, O.; Minko, T. Inhalation treatment of lung cancer: The influence of composition, size and shape of nanocarriers on their lung accumulation and retention Cancer Biol. Med. 2014, 11, 44-55
45. Garbuzenko, O. B.; Saad, M.; Betigeri, S.; Zhang, M.; Vetcher, A. A.; Soldatenkov, V. A.; Reimer, D. C.; Pozharov, V. P.; Minko, T. Intratracheal versus intravenous liposomal delivery of siRNA, antisense oligonucleotides and anticancer drug Pharm. Res. 2009, 26, 382-394
46. Ivanova, V.; Garbuzenko, O. B.; Reuhl, K. R.; Reimer, D. C.; Pozharov, V. P.; Minko, T. Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2 Eur. J. Pharm. Biopharm 2013, 84, 335-344